The PBAC recommends a change for all listings and brands of Rituximab to be added to the Unrestricted Benefits listings.
18
Oct
11
Oct
Leading ITP clinicians come together and deliver consensus guidelines for the treatment of (ITP) in adult patients.
09
Oct
ATAGI recommendation on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.
23
May
A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.
08
Apr
ATAGI has released a number of recommendations relating to the COVID-19 Vaccine.
18
Mar
Dr Norman Swan hosts an ABC podcast called ‘Coronacast’, where they talk all things COVID-19. In a recent episode, he talks about the vaccines, the occurrence of blood clots and ITP.
16
Mar
Australian experts confident in AstraZeneca vaccine despite pause in Europe. 7.30 with Leigh Sales (ABC), Dr Norman Swan discussed the the most scrutinised vaccine rollout in history, with the COVID-19 vaccine.
12
Feb
03
Nov
ITP Australia delivers a number of recommendations to improve treatment access for patients living with Immune Thrombocytopenia.
15
Apr
Review the latest treatment guidelines available for adults living with immune thrombocytopenia in Australia and New Zealand.